Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia

被引:22
作者
Tajiri, J [1 ]
Noguchi, S [1 ]
Murakami, N [1 ]
机构
[1] NOGUCHI THYROID CLIN & HOSP FDN,BEPPU,OITA,JAPAN
关键词
D O I
10.1089/thy.1997.7.575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This prospective study was designed to investigate the usefulness of granulocyte count measurements 4 hours after injection of granulocyte colony-stimulating factor (G-CSF) for detecting recovery from antithyroid drug (ATD)-induced granulocytopenia or agranulocytosis. Granulocyte and white blood cell counts were measured 4 hours and 24 hours after patients with ATD-induced granulocytopenia had been given an injection of 75 mu g of G-CSF (1.1 to 1.9 mu g/kg; 1.5 +/- 0.2 mu g/kg [mean +/- standard deviation]). Thirty-seven patients were studied and divided into three groups based on their initial granulocytopenic granulocyte count: 28 with mild (granulocyte count 0.501 to 1.0 x 10(9)/L), 6 with moderate (granulocyte count 0.101 to 0.5 x 10(9)/L), and 3 with severe (granulocyte count less than 0.1 x 10(9)/L) ATD-induced granulocytopenia. Twenty-five of the 28 patients with mild granulocytopenia and 4 of the 6 patients with moderate granulocytopenia were found to have recovered from the granulocytopenia both 4 hours and 24 hours after injection, and their granulocyte counts remained normal thereafter. However, the other 3 patients with mild granulocytopenia, 2 patients with moderate granulocytopenia, and all 3 patients with severe granulocytopenia had not recovered by either 4 or 24 hours after the G-CSF injection. Despite daily C-CSF injections, the granulocyte continued to decrease in most cases. It took 2 to 11 days for these counts to recover from granulocytopenia. These results indicate that granulocyte count measurement 4 hours after injection of G-CSF is useful for detecting recovery from ATD-induced granulocytopenia or agranulocytosis and for predicting disease severity. Accordingly, its measurement enables physicians to make an appropriate decision about whether a patient with ATD-induced granulocytopenia should be treated in the hospital or in the outpatient clinic.
引用
收藏
页码:575 / 578
页数:4
相关论文
共 9 条
[1]  
AZUMA J, 1989, RINSHO IYAKU, V5, P2231
[2]   PROPYLTHIOURACIL (PTU)-INDUCED AGRANULOCYTOSIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) [J].
BALKIN, MS ;
BUCHHOLTZ, M ;
ORTIZ, J ;
GREEN, AJ .
THYROID, 1993, 3 (04) :305-309
[3]   G-CSF LEVELS DURING SPONTANEOUS-RECOVERY FROM DRUG-INDUCED AGRANULOCYTOSIS [J].
FUKATA, S ;
MURAKAMI, Y ;
KUMA, K ;
SAKANE, S ;
OHSAWA, N ;
SUGAWARA, M .
LANCET, 1993, 342 (8885) :1495-1495
[4]   METHIMAZOLE-INDUCED AGRANULOCYTOSIS AND GRANULOCYTE-COLONY STIMULATING FACTOR [J].
HEINRICH, B ;
GROSS, M ;
GOEBEL, FD .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (07) :621-622
[6]   GRANULOCYTE COLONY STIMULATING FACTOR TREATMENT OF ANTITHYROID DRUG-INDUCED GRANULOCYTOPENIA [J].
TAJIRI, J ;
NOGUCHI, S ;
OKAMURA, S ;
MORITA, M ;
TAMARU, M ;
MURAKAMI, N ;
NIHO, Y .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (04) :509-514
[7]   ANTITHYROID DRUG-INDUCED AGRANULOCYTOSIS - THE USEFULNESS OF ROUTINE WHITE BLOOD-CELL COUNT MONITORING [J].
TAJIRI, J ;
NOGUCHI, S ;
MURAKAMI, T ;
MURAKAMI, N .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (03) :621-624
[8]   TREATMENT OF METHIMAZOLE-INDUCED AGRANULOCYTOSIS USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) [J].
TAMAI, H ;
MUKUTA, T ;
MATSUBAYASHI, S ;
FUKATA, S ;
KOMAKI, G ;
KUMA, K ;
KUMAGAI, LF ;
NAGATAKI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1356-1360
[9]   SUCCESSFUL TREATMENT OF METHIMAZOLE-INDUCED AGRANULOCYTOSIS BY GRANULOCYTE COLONY-STIMULATING FACTOR [J].
YOKOYAMA, K ;
SATO, T ;
NAKAJIMA, S ;
CHINO, M ;
KOMATSUMOTO, S ;
NARA, M ;
OKAMOTO, S .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 40 (01) :76-77